for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Laboratory Corp. of America Holdings

LH.N

Latest Trade

193.11USD

Change

3.34(+1.76%)

Volume

138,844

Today's Range

189.13

 - 

193.13

52 Week Range

98.02

 - 

205.91

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
189.77
Open
189.13
Volume
138,844
3M AVG Volume
17.43
Today's High
193.13
Today's Low
189.13
52 Week High
205.91
52 Week Low
98.02
Shares Out (MIL)
97.40
Market Cap (MIL)
18,483.60
Forward P/E
14.70
Dividend (Yield %)
--

Next Event

Q3 2020 Laboratory Corporation of America Holdings Earnings Release

Latest Developments

More

Labcorp Announces Q2 Earnings Per Share $2.37

U.S. FDA Authorizes First Diagnostic Test For Screening Of People Without Known Or Suspected COVID-19 Infection

Labcorp To Adopt Decentralized Clinical Trials, Expand Technology Ecosystem

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Industry

Healthcare Facilities

Contact Info

358 S MAIN ST

BURLINGTON, NC

27215-5837

United States

+1.336.2291127

https://www.labcorp.com

Executive Leadership

Adam H. Schechter

President, Chief Executive Officer, Director

Glenn A. Eisenberg

Chief Financial Officer, Executive Vice President

Judith C. Seltz

Chief Human Resource Officer, Executive Vice President

Lance V. Berberian

Executive Vice President, Chief Technology Officer, Chief Information Officer

Amy B. Summy

Executive Vice President, Chief Marketing Officer

Key Stats

1.78 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

10.2K

2018

11.3K

2019

11.6K

2020(E)

12.7K
EPS (USD)

2017

9.600

2018

11.020

2019

11.320

2020(E)

14.367
Price To Earnings (TTM)
51.71
Price To Sales (TTM)
1.61
Price To Book (MRQ)
2.51
Price To Cash Flow (TTM)
19.42
Total Debt To Equity (MRQ)
85.72
LT Debt To Equity (MRQ)
74.86
Return on Investment (TTM)
2.42
Return on Equity (TTM)
2.04

Latest News

Latest News

LabCorp says needs to run testing below full capacity for faster results

Laboratory Corporation of America Holdings <LH.N> said on Tuesday it has the capacity to run about 180,000 molecular tests a day and was delivering results in two-three days, but to maintain the speed it will have to perform below full capacity.

LabCorp says need to run testing below full capacity to maintain shorter turnaround time

Laboratory Corporation of America Holdings Chief Executive Officer Adam Schechter said on Tuesday COVID-19 testing should not be run at full capacity to ensure shorter turnaround time for results.

BRIEF-Humana To Offer Labcorp At-Home COVID-19 Test Collection, Collaborate With Walmart And Quest Diagnostics To Offer Drive-Thru Testing For Humana Members

* HUMANA TO OFFER LABCORP AT-HOME COVID-19 TEST COLLECTION AND COLLABORATE WITH WALMART AND QUEST DIAGNOSTICS TO OFFER DRIVE-THRU TESTING FOR HUMANA MEMBERS Source text for Eikon: Further company coverage:

LabCorp launches new neutralizing antibody test for COVID-19

LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus.

LabCorp launches new antibody test for COVID-19

LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus.

BRIEF-LabCorp Launches New Neutralizing Antibody Test

Laboratory Corporation of America Holdings:

LabCorp ties up with software provider to expand virtual clinical trials

Laboratory Corporation of America Holdings (LabCorp) said on Thursday it was partnering with software provider Medable to speed up the adoption of virtual clinical trials, as many participants are dropping out of ongoing studies due to the COVID-19 pandemic.

LabCorp to work with software provider for virtual clinical trials

Laboratory Corporation of America Holdings (LabCorp) said on Thursday it was collaborating with software provider Medable to accelerate adoption of virtual clinical trials.

LabCorp to make COVID-19 testing services available at workplaces

Diagnostic services provider LabCorp said on Thursday it would make its COVID-19 tests available at workplaces, as employers across the United States look to bring people back to work safely.

BRIEF-Labcorp - Launching A New Return To Work Service For Employers

* LABCORP - LAUNCHING A NEW RETURN TO WORK SERVICE FOR EMPLOYERS

LabCorp expands availability of at-home sample collection kit for COVID-19 test

LabCorp said on Tuesday its at-home sample collection kit for COVID-19 testing would now be available to all individuals with symptoms and possible exposure to the virus, after limiting delivery to healthcare workers during its launch last month.

LabCorp expands availability of at-home sample collection kit for COVID-19 testing

LabCorp said on Tuesday it has now made available its at-home sample collection kit for COVID-19 testing to all individuals with symptoms and possible exposure to the virus, after having limited delivery to healthcare workers last month.

BRIEF-Labcorp Q1 Loss Per Share $3.27

Laboratory Corporation of America Holdings:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up